Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What Will Be the Growth Trajectory of the Cell Therapy Market from 2024 to 2033?

In recent times, the size of the cell therapy market has seen speedy expansion. The market is set to inflate from $12.58 billion in 2023 to $14.72 billion in 2024, with a compound annual growth rate (CAGR) of 17.0%. This phenomenal growth in the historic period can be credited to factors such as initial research and discoveries, regulatory landmarks, clinical examinations and studies, trailblazing companies and early adopters, alongside market acceptance and perception.

The market size of cell therapy is predicted to experience a swift expansion in the forthcoming years. It is projected to escalate to a value of $25.86 billion by 2028, exhibiting a compound annual growth rate (CAGR) of 15.1%. Its growth in this projected timeframe can be credited to several factors such as moral and societal factors, investment and funding trends, consumer or patient demand, healthcare infrastructure, and quick innovation cycles. The major trends for this period include personalized medicine, emerging targeted therapies, advancements in gene editing technologies, expansion of stem cell research, developments in immunotherapy, and manipulation of microenvironments.

Claim Your Free Sample of the Global Cell Therapy Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

What Are the Primary Growth Drivers for the cell therapy Market?

The surge in chronic diseases is furthering the growth of the cell therapy market. The US Centers for Disease Control and Prevention identify chronic diseases as conditions that persist for a year or longer, require healthcare, and potentially limit day-to-day activities; including ailments such as heart disease, cancer, diabetes, and Parkinson’s disease. Stem cell therapy can be advantageous for individuals suffering from conditions such as spinal cord injuries, type 1 diabetes, Parkinson’s disease, heart disease, cancer, and osteoarthritis. A 2021 report by the Center for Disease Control and Prevention states that due to unhealthy diets and inadequate physical exercise, 6 in 10 US adults are plagued by a chronic disease and 4 in 10 are afflicted with two or more illnesses. As of December 2021, the Belgium-based International Diabetes Federation predicts that roughly 537 million people aged between 20 and 79 years are diabetic. This figure is expected to rise to 643 million by 2030, and to reach 783 million by 2045. Nearly half (240 million) of these predicted cases remain undiagnosed, and amongst the diagnosed, a significant majority lives in low and middle-income countries. The Parkinson’s Foundation predicted in 2021 that about 60,000 Americans would be newly diagnosed with Parkinson’s disease annually, with 10 million people worldwide suffering from this condition, ranking it as the second most common neurological disorder after Alzheimer’s. This rising incidence of chronic illnesses has stimulated demand for cell therapies and continues to fuel the progress of the cell therapy market.

What Are the Defining Segments of the Cell Therapy Market?

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

What Trends Are Revolutionizing Standards in the Cell Therapy Market?

Major market participants are forming strategic partnerships and collaborations to boost their product range and reach across different regions. For instance, Takeda, a Japanese pharmaceutical firm, took over GammaDelta Therapeutics, a US-based business specialising in cell therapies, in October 2021. This move aims to expedite the creation of allogeneic T cell therapies for solid tumours. Additionally, Charles River Laboratories, another US-based pharmaceutical firm, purchased Vigene Biosciences Inc., a biotech company, in June 2021. This acquisition enables Charles River to enhance its gene therapy skills, set up a comprehensive gene therapy solution in the US, and hasten its potential for long-term revenue and earnings growth.

Order Now for Fast Delivery of Your Cell Therapy Market Report!

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

What Regions Are Propelling Growth in the Cell Therapy Industry?

North America was the largest region in the cell therapy market in 2023. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Cell Therapy Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the cell therapy market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Cell Therapy Market Include

1. Cell Therapy Market Executive Summary

2. Cell Therapy Market Segments

3. Cell Therapy Market Size And Template Market Growth Rate

4. Key Cell Therapy Market Trends

5. Major Cell Therapy Market Drivers

……

25. Key Mergers And Acquisitions In The Cell Therapy Market

26. Top Cell Therapy Companies

27. Cell Therapy Market Opportunities And Strategies

28. Cell Therapy Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Plasma Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

Injectable Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report

Convalescent Plasma Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: